Serina Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | -90.4% | -90.4% | -68.3% |
| FY2018 | -100.7% | -100.7% | -70.3% |
| FY2019 | -548.0% | -548.0% | -163.3% |
| FY2020 | 212.4% | 212.4% | -276.8% |
| FY2021 | 73.3% | -633.2% | -275.0% |
| FY2022 | 60.8% | -1,147.1% | -322.8% |
| FY2023 | -16.3% | -16.3% | 58.8% |
| FY2024 | -1,738.1% | -1,738.1% | -165.7% |
| FY2025 | 51,843.2% | 51,843.2% | -276.0% |